MAP3K7 and breast carcinoma: MAP2K3 and MAP3K7 belong to the MAPK pathway, and activation of the MAPK pathway in breast cancer promotes proliferation, anti-apoptotic influence, and contributes to drug resistance, cancer cell survival, and invasion.